Results 121 to 130 of about 36,737 (275)
Multiple Myeloma : an update on disease biology and therapy [PDF]
Multiple myeloma is a malignancy of immunoglobulin producing plasma cells. Clinical features include bone pain due to lytic bone lesions or pathological fractures, anemia, symptomatic hypercalcemia, renal insufficiency, recurrent infections and ...
Cook, Rachel J., Dingli, David
core
Prediction of peptide and protein propensity for amyloid formation [PDF]
Understanding which peptides and proteins have the potential to undergo amyloid formation and what driving forces are responsible for amyloid-like fiber formation and stabilization remains limited.
A Quintas +80 more
core +5 more sources
Immunoglobulin (Ig) light chain (AL) amyloidosis is a clonal plasma cell disorder characterized by misfolded Ig light chain deposition in vital organs of the body, resulting in proteotoxicity and organ dysfunction.
Talha Badar +2 more
doaj +1 more source
Localized Nasopharyngeal Amyloidosis [PDF]
A mass in the nasopharynx often implies a malignancy in adults, particularly in the endemic areas of Epstein-Barr virus-associated undifferentiated carcinoma.
Abrams, K. +7 more
core +2 more sources
Suggestive Diagnostic Process in a Case of Multiple Myeloma with Gastrointestinal Immunoglobulin Light-Chain Amyloidosis Accompanied by Protein-Losing Enteropathy [PDF]
Katsuya Endo +15 more
openalex +1 more source
AL amyloidosis complicating monoclonal gammopathy of undetermined significance (MGUS) has usually a predominant glomerular deposition of lambda light chain. Heavy proteinuria is one of its cardinal manifestations.
Yijuan Sun +5 more
doaj +1 more source
Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [PDF]
Background. Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process. Methods.
Hopfer, Helmut +2 more
core
HSD78 Systemic Amyloid Light Chain (AL) Amyloidosis Patient Experience Research [PDF]
C Penaloza Ramos +5 more
openalex +1 more source
Journal of Hospital Medicine, Volume 21, Issue 2, Page 200-204, February 2026.
Gurpreet Dhaliwal +4 more
wiley +1 more source
[Efficacy and safety of daratumumab in the treatment of advanced light chain amyloidosis].
Kai Shen +6 more
openalex +2 more sources

